Hepatitis C - GoGirlsMusic.com Names HepCAware.org the Official Charity of the 2006 'Invasion of The GoGirls'

GoGirlsMusic.com Names HepCAware.org the Official Charity of the 2006 'Invasion of The GoGirls'
[Press Release] PR Web via Yahoo! News - Mar 04 4:00 AM
(PRWEB) March 4, 2006 -- GoGirlsMusic.com names HepCAware.Save to My Web

HEALTH NOTES: Patients e-records facing legal hurdles
Kansas City Star - Feb 28 12:24 PM
Although information technology promises to reduce medical errors and bolster efficiency, the road to the electronic promised land is fraught with legal potholes.Save to My Web

Victim of tainted blood scandal puts human face on criminal trial
phillyburbs.com - Feb 08 3:10 PM
TORONTO - James Kreppner, his legal career halted when he contracted HIV and Hepatitis C through tainted blood, sat in the back of a courtroom Wednesday, putting a human face on a criminal trial resulting from Canada's worst public health scandal.Save to My Web

'Silent killer' driven out of the shadows: Hepatitis
Chillicothe Gazette - Feb 20 4:39 AM
There was a time when Arline Loh of Wilmington, Del., didn't tell people she has hepatitis B. "It carries such a stigma," says Loh, 57, an information technology expert who retired three months ago because of liver damage caused by the disease.Save to My Web

Hepatitis C - VX-950 To Get Fast Tracked

VX-950 To Get Fast Tracked
As you may recall we've been saying VX-950 is the revolutionary new therapy to watch for HCV. Now it looks like the FDA agrees this treatment is quite promising and deserving of faster approval than a lesser worthy approach. Another...

Ultrasound
Title: UltrasoundCategory: Procedures and TestsCreated: 12/31/1997Last Editorial Review: 10/15/2005

Liver Blood Tests
Title: Liver Blood TestsCategory: Procedures and TestsCreated: 6/2/1998Last Editorial Review: 8/27/2005

Primary Biliary Cirrhosis
Title: Primary Biliary CirrhosisCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 9/17/2005

Hepatitis C - PAGE--Hepatitis C

PAGE--Hepatitis C
This web site requires JavaScript and Microsoft Internet Explorer 5.0 or better to display and function properly. ... CDC Viral Hepatitis C Info. Summary Slides ...

Hepatic Pathology
This is a case of viral hepatitis C, which in half of cases leads to chronic liver disease. The extent of chronic hepatitis can be graded by the degree of activity (necrosis and inflammation) and staged by the degree of fibrosis.

Chronic viral hepatitis C: management update -- Hepatitis C Outreach Project
... 8:27:35 PDT. Chronic viral hepatitis C: management update Klaus S ... Introduction Diagnosis of chronic viral hepatitis C Assessment of patients with chronic viral hepatitis C ...

PPC in Viral Hepatitis
PPC (polyenylphosphatidylcholine) has been found to decrease serum aminotransferases in experimental hepatitis. ... PPC increased the response rate to IFN in chronic viral hepatitis C (71% versus 51% in the placebo group). Prolonged PPC ...

Hepatitis C - 009: CHRONIC HEPATITIS C: A PEDIATRIC PERSPECTIVE

009: CHRONIC HEPATITIS C: A PEDIATRIC PERSPECTIVE
Clinical features of chronic hepatitis C virus (HCV) infection in children may differ from that of adults. Aim: To present our clinical experience with children infected by HCV

Hospital Practice: Chronic Hepatitis C: Early Intervention
Chronic Hepatitis C: Early Intervention RAYMOND S. KOFF University of Massachusetts Chronic hepatitis C infection is the most common liver disease in the United States; it accounts for up to 12,000

index.html
of the patients with chronic hepatitis C, including some with advanced cirrhosis and liver failure. If you are cured, your viral level falls to undetectable during

Sloan-Kettering - Find a Clinical Trial
Phase II Study of Sho-saiko-to in Patients with Chronic Hepatitis C Who Cannot Use Interferon [Protocol 02-073]

Hepatitis C - Hepatitis B

Hepatitis B
Title: Hepatitis BCategory: Diseases and ConditionsCreated: 1/26/2001 11:58:00 AMLast Editorial Review: 9/21/2005

Hepatitis C
Title: Hepatitis CCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 9/17/2005

Alcoholism Facts
Title: Alcoholism FactsCategory: Health FactsCreated: 8/9/2005Last Editorial Review: 8/29/2005

Pegasys Shown More Effective In Study
Schering and Roche are taking part in dueling press releases. Each claiming their solution is better. Either way, they seem to be splitting hairs regarding effectiveness. There is no clear winner when they keep firing PR salvos back and forth....

Hepatitis C - MedMira Rapid Test

MedMira Rapid Test
The start of the New Year was accompanied by the European Patent Office granting a patent for a rapid HCV test. Now that the technology is here, let's hope the test proves accurate, with high levels of selectivity and specificity....

Hepatitis C
Title: Hepatitis CCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 9/17/2005

Infectious Mononucleosis
Title: Infectious MononucleosisCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 12/14/2005

A Breakthrough Discovery for Hepatitis C
The state of Florida has recently produced a study illuminating the replication and mutation of the Hepatitis C virus. This kind of progress represents a giant leap forward in tracking this persistent virus, which likely means more accurate and efficient...

Hepatitis C - About the Hawaii Center for Volcanology

About the Hawaii Center for Volcanology
... The Hawaii Center for Volcanology (HCV) was conceived and created in 1992 as a cooperative ... the primary organizations listed below. HCV is presently undergoing re-organization and ...

Interaction between HIV-1 and HCV infections: towards a new entity? -- Winnock et al. 53 (6): 936 -- Journal of ...
... virus (HIV) and hepatitis C virus (HCV) share the same modes of transmission, HIVHCV co-infected patients are relatively common ...

Dept. Molecular Virology, Division HCV
Site of the Department of Molecular Virology of the University of Heidelberg ... HCV is the major etiologic agent of sporadic and transfusion-associated non-A, non-B hepatitis worldwide ... to the high rate of chronicity, HCV infections are a serious medical problem ...

Aidsmap | HCV/HIV coinfection guidelines may lead to unnecessarily premature HAART discontinuation
YOU ARE HERE: HCV/HIV coinfection guidelines may lead to unnecessarily premature HAART discontinuation. Edwin J. Bernard, Monday, September 26, 2005 ... Current HIV/hepatitis C (HCV) guidelines suggesting highly active antiretroviral therapy (HAART ... Cincinnati, Ohio, found that although HCV viral load and ALT levels flared ...

Hepatitis C - Janis and Friends Hep C Web Site

Janis and Friends Hep C Web Site
The entry page to the Microsoft Office Web site. Find updates, downloads, assistance, and more for your Office programs.

Hepatitis C Caring Ambassadors Program - Home Page
... HCCAP Newsletters | HCCAP Press Releases | HCV in the News | Read or Download Choices | Order Hep C Choices Book | Order Hep C Choices Flyer.

Hepatitis C
Copyright 1998 Trustees of Dartmouth College. An Important Message from Dr. Koop Contents · Search · Glossary · About the Site.

Hepatitis Connections International
Hep-C ALERT! An activist organization for Hepatitis C Immunization Action Coalition/Hepatitis B Coalition · International Society for Environmental ...

Hepatitis C - Experts warn public on dangers of Hep C

Experts warn public on dangers of Hep C
ABC Online, Australia - Feb 18, 2006ELIZABETH JACKSON: Health experts are warning that Australia doesn't have the resources to deal with a burgeoning epidemic of viral hepatitis, a debilitating ...

Hep C key lies in new needles, not education
Australian, Australia - Feb 19, 2006PROVIDING clean needles to injecting drug users is almost four times more effective in fighting the rising epidemic of hepatitis C than the education and ...

Hepatitis C - silent epidemic
Thunder Bay's Source, Canada - Feb 23, 2006... in attendance. The most common way to contract Hep C is through blood, and is often related to the sharing of needles. However thousands ...

Health calendar
Asheville Citizen-Times, NC - Feb 21, 2006... HEP C HOPE: State Representative Susan Fisher will discuss health care in North Carolina at 6 pm at MAHEC, 501 Biltmore Ave. Call 350-7500. ...

Hepatitis C - HCV

HCV
hepatitis C virus (HCV) was first definitively identified by molecular cloning ... Pathophysiology of hepatitis C virus infection and related liver disease. ...

HCV Sequence Database - BLAST search
This BLAST searches the HCV sequence database. The interface can handle both nucleotide and amino ... Questions or comments? Contact us at hcv-info@lanl.gov ...

Housing Choice Vouchers - HUD
The Office of Public and Indian Housing ensures safe, decent, and affordable housing, creates opportunities for residents' self-sufficiency and economic ...

Coping with HCV Infection: Alternative or Complementary Approaches ...
If you want to try alternative treatments to help you cope with your HCV ... Aromatherapy might help you cope with the side effects of your HCV treatment. ...

Hepatitis C - GS1 unveils innovative track and trace scheme

GS1 unveils innovative track and trace scheme
ElectricNews.net via Yahoo! UK & Ireland News - Feb 27 6:57 AM
A world-first application of track and trace technology to solve a patient safety issue in Ireland may herald a new era for global supply chain management.Save to My Web

REVIEW PUBLISHED ON INFECTED BLOOD PRODUCTS
Government News Network - Feb 27 4:24 AM
A review in to how patients were infected with Hepatitis C and HIV through contaminated blood in the 1970s and early 1980s, was published today.Save to My Web

Five years is already far too long
The Journal - Feb 28 12:09 AM
Five years is already far too long - Five years will strike most people as time enough to make sure every bridge in Britain is as safe as can be in the event of a crash.Save to My Web

Compensation for Neary victims to be agreed within weeks
Irish Examiner - Mar 01 10:14 AM
The Government will agree on a compensation scheme for victims of disgraced obstetrician Michael Neary within a fortnight, it emerged this afternoon.Save to My Web

Gen-Probe Receives National Medal of Technology
Medical Device Link - Feb 27 12:11 PM
In November, President Bush named in vitro diagnostics manufacturer Gen-Probe Inc. (San Diego) as one of seven National Medal of Technology laureates for 2004. The company was recognized for the development and commercialization of its Procleix line of nucleic acidbased blood-screening tests.Save to My Web

Hepatitis C - A Summary of Chronic Hepatitis C InfectionHepatitis C

A Summary of Chronic Hepatitis C Infection

Hepatitis C is a stealthy virus that mutates while hiding in liver cells and other organ cells like the spleen and gall bladder. The fact that the viral cells "hide" makes it very difficult for the body's immune system to eradicate it. Hepatitis C is a slowly progressing disease sometimes taking many years until symptoms are noticeable. It is at this point that the virus has reached advanced chronic stage and becomes difficult to eradicate. Hepatitis C results in 8,000 to 10,000 deaths annually. Hepatitis C is also the leading cause of liver transplants in the U.S.

Hepatitis C infection is caused by blood contact with someone who has the virus infection himself. The transmission of the virus can occur by illicit drug use with needles, sharing toothbrushes or razors with an infected person, by sexual means, by unsanitary tattooing or by exposure to blood at your workplace (like a hospital or blood bank). Some HCV infection may have been caused by receiving blood from a transfusion prior to 1992.

Hepatitis C is diagnosed via a blood test. Usually, the first thing that is noticed is that the liver enzyme levels for ALT and AST are elevated well above normal levels. Further investigation via HCV-RNA testing identifies whether the Hepatitis C virus is in your blood or not. Other tests for HCV include qualitative viral load tests, which measure the RNA particles in your blood. If you are being treated for HCV, your doctor is probably using either a HCV-RNA or viral load test to determine the effectiveness of the treatment.

The symptoms of Hepatitis C infection often do not occur in a person until 20 years after he/she had been infected. Since the HCV infects the liver and the liver is the organ in the body that makes all the energy for our daily activities possible, liver function deterioration often results in fatigue. Fatigue is the primary complaint or symptom of HCV infection. Other more severe symptoms are jaundice (yellowing of the skin/eyes), bile retention (which can cause jaundice), portal vein hypertension, skin rashes and itching, and autoimmune problems resulting from your body's immune system attacking normal cells.

Long term HCV infection may result in fibrosis or even cirrhosis of the liver. Fibrosis results from unchecked liver inflammation. As the HCV infection progresses, the damage to the liver results in scarring or hardening of the liver cells (fibrosis). Long term fibrosis may lead to cirrhosis which is when the scarring from fibrosis overtakes the normal liver cell structure causing deformity and loss of function in the liver. About 15%-20% of HCV patients end up with cirrhosis. A liver biopsy is currently the most accurate means of determining the amount of inflammation and fibrosis the liver has sustained.

Hepatitis C progression in the body can take several years or even decades to come to chronic stage or to a stage where severe liver damage is evident. This period of time allows a person to determine how to properly treat the disease and to decide on a course of disease management. Currently, the main treatment for HCV infection to eradicate the virus is combo alpha-interferon and Ribavirin. Sometimes a doctor may prescribe interferon alone. Interferon comes in standard form or in pegylated form. Standard form interferon is administered 3 times per week, while the pegylated form is administered only once per week. Your body makes its own interferon, which is a protein that fights viral infection and viral replication.

Hepatitis C may often be managed by taking herbal and vitamin supplements that help your body fight infection and limit inflammation. These supplements help your liver with the inflammation and give it the nutrients it needs to regenerate healthy new cells. Your doctor can recommend alternative or adjunct solutions you may want to try.

Proper treatment of the disease, a healthy and active lifestyle, a good diet, abstinence from alcohol and stress management are important factors in controlling Hepatitis C progression.

About the Author

Greg Lietz is a freelance writer and internet businessman. His main website is http://www.theonlinebizplace.com where he provides content about internet based business opportunities and different niche interests. This article may be freely printed when the bio information is included.

Hepatitis C - Tata Motors: Bumpy ride

Tata Motors: Bumpy ride
Business Standard India - Feb 09 10:43 AM
Tata Motors operating profit margin dropped by 1.04 basis points y-o-y to 12.28 per cent in the Q3 FY06. Operating profit increased by just 7.22 per cent to Rs 623.06 crore, though net sales have gone up by 16.31 per cent.Save to My Web

Aethlon CEO to Present at Today's Bird Flu Summit
RedNova - Feb 27 4:46 AM
Aethlon Medical, Inc. (OTCBB:AEMD), a pioneer in developing therapeutic devices for infectious disease, announced that its Chairman and CEO, James A. Joyce, will give a presentation today at Washington DC's first Bird Flu Summit. Mr.Save to My Web

Nova may stage local elims for Shakey's 16-Under volley
Sun Star - Feb 22 7:04 PM
THE ongoing Negros Occidental Volleyball Association-Negros Occidental Cultural and Sports Foundation age-group volleyball competition girls 16-Under division may not serve as the qualifying tournament for the forthcoming Shakey's 16-Under girls competition.Save to My Web

Boxing programs in need of gov't funding: group
Sun Star - Feb 15 9:04 PM
THE Negros Amateur Boxing Association (Naba) needs the financial support of the Philippine Sports Commission (PSC) in order for it to immediately implement its regular grassroots development program, Naba officials said.Save to My Web

Call for public health intervention to treat young injection drug users infected with the hepatitis C virus
News-Medical-Net - Feb 07 4:13 AM
In a recent study published in the journal Clinical Infectious Diseases, scientists from New York City, Baltimore, Seattle, and San Diego called for an immediate public health intervention to treat young injection drug users infected with the hepatitis C virus (HCV).Save to My Web

Hepatitis C - People With Chronic Hepatitis B To Benefit From Guidance On New Drugs

People With Chronic Hepatitis B To Benefit From Guidance On New Drugs
Medical News Today - The National Institute for Health and Clinical Excellence (NICE) has today issued guidance for the NHS in England and Wales recommending the use of two new drugs for treating hepatitis B. The guidance states that : - - - - Peginterferon alfa-2a is

Liver transplant program restarted
Arizona Daily Wildcat - Dr. Thomas Boyer, left, medical director of liver transplants at UMC, and transplant surgeon Dr. Ernesto P. Molmenti, who performed Thursday's surgery, discuss the first liver transplant performed at UMC in four years. The reactivation of UMC's Liver

Pharmacy Benefit
Managed Healthcare Executive - HEPATITIS B AND C are serious viral diseases that can lead to lifelong infection, cirrhosis, liver cancer, liver failure and death. They often produce chronic, hidden infections. An estimated 1.25 million Americans are infected with hepatitis B, and

BUSINESS DIGEST
San Jose Mercury News - Rambus, a Los Altos designer of high-speed memory chips, won a ruling Thursday requiring Samsung Electronics to turn over documents from a Justice Department price-fixing investigation. Rambus seeks the documents for a lawsuit in San Francisco

Teen Determined To Get Father Liver Transplant
WMTW - YORK, Maine -- Every girl dreams of having her father walk her down the aisle on her wedding day. One York County girl just hopes her father will be there. Katie Prouty s dad has hepatitis C. Now she is on a mission to get the disease on the radar

What's Happening
Tahoe Daily Tribune - The South Tahoe High School Booster Club will hold its March meeting at 6 p.m. Wednesday in the high school library. The upcoming joint golf tournament with Whittell High School will be discussed. New proposals to enhance athletics will be addressed

Hepatitis C - HEPATITIS C PATIENT INFO - What You MUST Know ...

HEPATITIS C PATIENT INFO - What You MUST Know ...
Hepatitis C. Find answers to your most pressing questions. Award winning site developed by a patient to help you learn the facts...

WHO | Hepatitis C
Hepatitis C is a viral infection of the liver which had been referred to as ... Thus, from a global perspective, the greatest impact on hepatitis C disease ...

VA National Hepatitis C Program
The Veterans Affairs National Hepatitis C Web site provides information about viral hepatitis for health care providers inside and outside the VA system, ...

Hepatitis Central, Current Information On Hepatitis C & treatments ...
Hepatitis C Information Center at Hepatitis-Central.com Featuring the latest news about Hepatitis C infection, Hepatitis C diagnosis, Hepatitis C symptoms, ...

Hepatitis C - A Summary of Chronic Hepatitis C InfectionHepatitis C

A Summary of Chronic Hepatitis C Infection

Hepatitis C is a stealthy virus that mutates while hiding in liver cells and other organ cells like the spleen and gall bladder. The fact that the viral cells "hide" makes it very difficult for the body's immune system to eradicate it. Hepatitis C is a slowly progressing disease sometimes taking many years until symptoms are noticeable. It is at this point that the virus has reached advanced chronic stage and becomes difficult to eradicate. Hepatitis C results in 8,000 to 10,000 deaths annually. Hepatitis C is also the leading cause of liver transplants in the U.S.

Hepatitis C infection is caused by blood contact with someone who has the virus infection himself. The transmission of the virus can occur by illicit drug use with needles, sharing toothbrushes or razors with an infected person, by sexual means, by unsanitary tattooing or by exposure to blood at your workplace (like a hospital or blood bank). Some HCV infection may have been caused by receiving blood from a transfusion prior to 1992.

Hepatitis C is diagnosed via a blood test. Usually, the first thing that is noticed is that the liver enzyme levels for ALT and AST are elevated well above normal levels. Further investigation via HCV-RNA testing identifies whether the Hepatitis C virus is in your blood or not. Other tests for HCV include qualitative viral load tests, which measure the RNA particles in your blood. If you are being treated for HCV, your doctor is probably using either a HCV-RNA or viral load test to determine the effectiveness of the treatment.

The symptoms of Hepatitis C infection often do not occur in a person until 20 years after he/she had been infected. Since the HCV infects the liver and the liver is the organ in the body that makes all the energy for our daily activities possible, liver function deterioration often results in fatigue. Fatigue is the primary complaint or symptom of HCV infection. Other more severe symptoms are jaundice (yellowing of the skin/eyes), bile retention (which can cause jaundice), portal vein hypertension, skin rashes and itching, and autoimmune problems resulting from your body's immune system attacking normal cells.

Long term HCV infection may result in fibrosis or even cirrhosis of the liver. Fibrosis results from unchecked liver inflammation. As the HCV infection progresses, the damage to the liver results in scarring or hardening of the liver cells (fibrosis). Long term fibrosis may lead to cirrhosis which is when the scarring from fibrosis overtakes the normal liver cell structure causing deformity and loss of function in the liver. About 15%-20% of HCV patients end up with cirrhosis. A liver biopsy is currently the most accurate means of determining the amount of inflammation and fibrosis the liver has sustained.

Hepatitis C progression in the body can take several years or even decades to come to chronic stage or to a stage where severe liver damage is evident. This period of time allows a person to determine how to properly treat the disease and to decide on a course of disease management. Currently, the main treatment for HCV infection to eradicate the virus is combo alpha-interferon and Ribavirin. Sometimes a doctor may prescribe interferon alone. Interferon comes in standard form or in pegylated form. Standard form interferon is administered 3 times per week, while the pegylated form is administered only once per week. Your body makes its own interferon, which is a protein that fights viral infection and viral replication.

Hepatitis C may often be managed by taking herbal and vitamin supplements that help your body fight infection and limit inflammation. These supplements help your liver with the inflammation and give it the nutrients it needs to regenerate healthy new cells. Your doctor can recommend alternative or adjunct solutions you may want to try.

Proper treatment of the disease, a healthy and active lifestyle, a good diet, abstinence from alcohol and stress management are important factors in controlling Hepatitis C progression.

About the Author

Greg Lietz is a freelance writer and internet businessman. His main website is http://www.theonlinebizplace.com where he provides content about internet based business opportunities and different niche interests. This article may be freely printed when the bio information is included.

Hepatitis C - MIGENIX to Participate in "Breakthroughs in Hepatitis" Focus Session at the BIO CEO & Investor Conference in New York

MIGENIX to Participate in "Breakthroughs in Hepatitis" Focus Session at the BIO CEO & Investor Conference in New York
[Press Release] PR Newswire via Yahoo! Finance - Feb 13 10:26 AM
MIGENIX Inc. , a clinical-stage developer of drugs for infectious and degenerative diseases, has been selected to participate in the "Breakthroughs in Hepatitis" focus session at the 8th Annual BIO CEO & Investor Conference in New York City, February 14th and 15th.Save to My Web

YOU ARE HERE:
Aidsmap - Feb 17 4:51 AM
Virological response to hepatitis C therapy after four weeks appears to predict who will have a successful response to a full course of treatment in HIV-positive people coinfected with hepatitis C genotypes 1 or 3, according to findings from two studies presented last week at the Thirteenth Conference on Retroviruses and Opportunistic Infections in Denver.Save to My Web

Coley Pharmaceutical Group Initiates Phase II Clinical Study of Actilon(TM) for Hepatitis C
[Press Release] PR Newswire via Yahoo! Finance - Feb 23 5:30 AM
Coley Pharmaceutical Group, Inc. today announced the initiation of a randomized Phase II clinical study of Actilon for the treatment of patients with chronic Hepatitis C infection.Save to My Web

FDA Grants Fast Track Designation To Oral HCV Protease Inhibitor SCH 503034, Schering-Plough Reports
Medical News Today - Jan 30 4:21 PM
Schering-Plough today reported that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its investigational oral hepatitis C protease inhibitor (SCH 503034), currently in Phase II clinical development for the treatment of chronic hepatitis C virus (HCV) infection. The FDA granted Fast Track designation for the following reasons: The proposed first indication for SCH Save to My Web

Hepatitis C - Hepatitis C

Hepatitis C
Jackson Gastroenterology's Web Site includes office information and paient education material on digestive and liver disorders, and nutrition. Endoscopic procedures that help in diagnosis and treatment are also described. ... What is Hepatitis C? Hepatitis C is caused by a virus (medically abbreviated as HCV). This type of viral hepatitis ... However, the hepatitis C virus is a "quick-change" artist ...

Hepatitis C Caring Ambassadors Program - Home Page
The Hepatitis C Caring Ambassadors Program is a non-profit organization working in many arenas to better the lives of people with hepatitis C

WebMD: Hepatitis C Topic Overview
What is hepatitis C and what causes it? Hepatitis C is a liver disease caused by infection with the hepatitis C virus. It is the most common blood-borne infection in the United States, affecting at...

Hepatitis Central
Information and support for people with dealing with Hepatitis C (HCV) infection.

Hepatitis C - Learn more from MedlinePlus
Find the latest news stories, overviews, research and more on Hepatitis C from MedlinePlus, the National Library of Medicine's consumer health site.

Hepatitis C - YOU ARE HERE:

YOU ARE HERE:
Aidsmap - Feb 17 4:51 AM
Virological response to hepatitis C therapy after four weeks appears to predict who will have a successful response to a full course of treatment in HIV-positive people coinfected with hepatitis C genotypes 1 or 3, according to findings from two studies presented last week at the Thirteenth Conference on Retroviruses and Opportunistic Infections in Denver.Save to My Web

Novelos Therapeutics Submits ''Dirty Bomb'' Treatment Proposal to U.S. Government
[Press Release] Business Wire via Yahoo! Finance - Feb 22 5:30 AM
NEWTON, Mass.----Feb. 22, 2006--Novelos Therapeutics, Inc. , a biotechnology company focused on the development of therapeutics to treat cancer and hepatitis, today announced that in response to a recent Request for Proposal from the Department of Health and Human Services it has submitted a proposal for the use of NOV-002 to treat subjects exposed to lethal radiation.Save to My Web

Novartis and Idenix seek European approval of telbivudine (LDT600) for the ...
Financial.de - Feb 07 12:56 AM
Basel, February 7, 2006 - Novartis ( News / Kurs / Chart / Board ) and Idenix Pharmaceuticals, Inc. announced today the European submission of telbivudine (LTD600) for approval as a novel treatment for patients affected by chronic hepatitis B (CHB), a potentially fatal disease estimated to affect more than three million people in Europe1 and over 350 million people worldwide.Save to My Web

FDA Grants Fast Track Designation To Oral HCV Protease Inhibitor SCH 503034, Schering-Plough Reports
Medical News Today - Jan 30 4:21 PM
Schering-Plough today reported that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its investigational oral hepatitis C protease inhibitor (SCH 503034), currently in Phase II clinical development for the treatment of chronic hepatitis C virus (HCV) infection. The FDA granted Fast Track designation for the following reasons: The proposed first indication for SCH Save to My Web

XTL Biopharmaceuticals to Present at the JPMorgan Small Cap Conference
RedNova - Feb 13 2:30 AM
NEW YORK, February 13 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals, Ltd. , a biopharmaceutical company developing drugs against hepatitis, announced today that Ron Bentsur, Chief Executive Officer, will present an overview of the Company at The JPMorgan Small Cap Conference in Philadelphia.Save to My Web

XTL Biopharmaceuticals to Present at the JPMorgan Small Cap Conference
[Press Release] PR Newswire via Yahoo! Finance - Feb 13 12:05 AM
XTL Biopharmaceuticals, Ltd. , a biopharmaceutical company developing drugs against hepatitis, announced today that Ron Bentsur, Chief Executive Officer, will present an overview of the Company at The JPMorgan Small Cap Conference in Philadelphia.Save to My Web

Hepatitis C - Hepatitis Immunization Rates Remain Less than Half for Gay and

Hepatitis Immunization Rates Remain Less than Half for Gay and
Prev by Date: Lamivudine does not increase the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B Next by Date: Comparison of treatments of chronic hepatitis B in children

VIRAL HEPATITIS :: next.luxurymat.org :: Viral Hepatitis
Top 10 articles: Outlet stores in orlando Lucerne valley real estate Keystone ford viral heaptitis ,

Viral Hepatitis
viral hepatits viral hepatitiis viral hepatiti viral hepatitiss ivral hepatitis vrial hepatitis viarl hepatitis virla hepatitis vira lhepatitis viralh epatitis viral ehpatitis viral hpeatitis viral heaptitis viral

World J Gastroenterol
Lamivudine does not increase the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B. Yang SS, Hsu CT, Hu JT, Lai YC, Wu CH

Nurses and Hepatitis C
Officers Coinfection HIV & Viral Heaptitis: a guide December 2003 Third Edition Produced in Association with the Australian Liver Association, Gastroenterological Society of Australia

Hepatitis C - People With Chronic Hepatitis B To Benefit From Guidance On New Drugs

People With Chronic Hepatitis B To Benefit From Guidance On New Drugs
Medical News Today - The National Institute for Health and Clinical Excellence (NICE) has today issued guidance for the NHS in England and Wales recommending the use of two new drugs for treating hepatitis B. The guidance states that : - - - - Peginterferon alfa-2a is

Tainted-blood trial will go ahead: Crown
CBC News - A Crown prosecution team says it has enough evidence to press ahead with the tainted-blood trial of the former head of the Canadian Red Cross and other health officials. Dr. Roger Perrault enters court in Toronto, Tuesday. "It is the intention of the

GSK Announces Start Of Eltrombopag Phase III Worldwide Clinical Trial
Medical News Today - GlaxoSmithKline plc (GSK) announced today the commencement of a worldwide clinical trial to investigate the safety and efficacy of eltrombopag (SB-497115-GR) as a once-daily orally-administered drug for adult patients with previously-treated

Enzo Awarded Patent for Phosphate Labeling for DNA Diagnostic and
Genetic Engineering News - Enzo Biochem, Inc. (NYSE:ENZ) announced today that its subsidiary, Enzo Life Sciences, Inc., has been granted U.S. Patent No. 6,992,180, entitled "Oligo-or polynucleotides comprising phosphate-moiety labeled nucleotides," describing techniques

Crown to press ahead
Regina Leader-Post - TORONTO -- The criminal case against a former director of the Canadian Red Cross arising out of the tainted blood scandal will go ahead. The Crown announced today it would proceed even though a key prosecution expert cast doubt on whether a

Hepatitis C - Hep-C Quilt

Hep-C Quilt
International Hep-C Quilts The Hep-C quilts are made up of patches submitted by people from all over the world with Hepatitis C. They are sewn together by me, Marie Stern, in my spare time

Hep C Bulletin
Some persons with liver damage due to hep C may develop cirrhosis (scarring) of the liver and liver failure, which may take many years to develop. HOW CAN I PROTECT MYSELF FROM GETTING HEP C AND

Peel Gets Hip 2 Hep C Links
Hep C Connection: Hepatitis C Network and Support System http://www.hepc-connection.org/ Hepatitis C Council of New South Wales (Australia) http://www.hepatitisc.org.au

HepCnet, Hepatitis C information support and resources, Hep C support
Hep C FAQ | Nutrition & Hep C | Nutrition & Cirrhosis Drugs & Liver Damage | Hep C Tests | Scoring/Staging Hepatitis C & Cirrhosis

HEP C MATCH: Hepatitis C Dating, Hepatitis C information, Hep-C chat
At Hep C Match you will find Hepatitis C Support from other members and potential dates (or mates) you will meet through this Hepatitis C Dating website